- Presented at NASP 2020 Annual Meeting, September 2020
- Presented at NASP 2019 Annual Meeting, September 2019
- Presented at AMCP 2019 Annual Meeting, March 2019
"Technology-enabled Specialty Pharmacy Utilization of the Routine Assessments of Patient Index Data 3 (RAPID 3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patients - A Retrospective Review"
- Presented and won 1st Place at NASP 2018 Annual Meeting, November 2018
Value-based care is the future. And, the future is now. Manufacturers, payers & providers need to improve patient health & mitigate skyrocketing costs. Specialty pharmacies are well-poised to support stakeholders in the movement toward value-based care. One approach is to fundamentally shift from old paradigms to systemizing improved outcomes—with the ability to consistently prove them.
Specialty pharmacies have a growing responsibility to raise this bar. To stay afloat & secure competitive contracts, specialty pharmacies must systematize & crystallize the successful diagnosis, monitoring & management of complex conditions—all while mastering the daunting tasks of defining the parameters & guidelines that indicate what “success” actually means for each unique patient. And, how it affects manufacturers', payers' & providers' products & services.
How can you systematize success for your pharmacy? When it comes to improved outcomes, Therigy has the technology, tools, network and subject matter expertise to help you get there.
Therigy enables the identification of opportunities to investigate, research, and demonstrate specialty therapy care outcomes through: